CERo Short Term Debt from 2010 to 2024

CEROW Stock   0.01  0.01  30.35%   
CERo Therapeutics Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 691.7 K in 2024. During the period from 2010 to 2024, CERo Therapeutics Short Term Debt regression line of quarterly data had mean square error of 2 B and geometric mean of  608,502. View All Fundamentals
 
Short Term Debt  
First Reported
2010-12-31
Previous Quarter
773.2 K
Current Value
691.7 K
Quarterly Volatility
56.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CERo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CERo Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 121.5 K, Interest Income of 121.5 K or Depreciation And Amortization of 994.6 K, as well as many indicators such as . CERo financial statements analysis is a perfect complement when working with CERo Therapeutics Valuation or Volatility modules.
  
Check out the analysis of CERo Therapeutics Correlation against competitors.

Latest CERo Therapeutics' Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of CERo Therapeutics Holdings over the last few years. It is CERo Therapeutics' Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CERo Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

CERo Short Term Debt Regression Statistics

Arithmetic Mean610,686
Geometric Mean608,502
Coefficient Of Variation9.24
Mean Deviation40,698
Median585,250
Standard Deviation56,412
Sample Variance3.2B
Range188K
R-Value0.65
Mean Square Error2B
R-Squared0.43
Significance0.01
Slope8,245
Total Sum of Squares44.6B

CERo Short Term Debt History

2024691.7 K
2023773.2 K
2022672.4 K

About CERo Therapeutics Financial Statements

CERo Therapeutics investors use historical fundamental indicators, such as CERo Therapeutics' Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CERo Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt773.2 K691.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CERo Stock Analysis

When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.